loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Certificates of Suitability (CEPs) for r1_cep_2010_330___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 Contipro a.s. Dolní Dobrouč CZ (1)

filter

01 Sodium hyaluronate, Type II (intrinsic viscosity: not higher than 0.70 m3/kg), from fermentation, for parenteral administration including intra-articular administration and intra-ocular use (1)

filter

01 Czech Republic (1)

filter

01 Valid (1)

URL Supplier Web Content
R1-CEP 2010-330 - Rev 01
Valid
Chemical
2017-10-04
1472
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-330 - Rev 01 of Contipro A.s. Dolní Dobrouč Cz

Looking for Certificates of Suitability (CEPs) for R1-CEP 2010-330 - Rev 01 of Contipro A.s. Dolní Dobrouč Cz 1

20

Contipro A.s. Dolní Dobrouč Cz, based in Czech Republic, is a pharmaceutical company.

One of their significant offerings is Sodium hyaluronate, Type II (intrinsic viscosity: not higher than 0.70 m3/kg), from fermentation, for parenteral administration including intra-articular administration and intra-ocular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-330 - Rev 01

This Chemical Type CEP, issued on October 04, 2017, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 1472 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY